Evidence map›Paper›PMID 14978203›Full record

ArticleThe Journal of physiology2004

P2Y purinergic receptor regulation of CFTR chloride channels in mouse cardiac myocytes.

Shintaro Yamamoto-Mizuma, Ge-Xin Wang, Joseph R Hume

Open access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Phenomics of cardiac chloride channels.Comprehensive Physiology · 2013
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Interaction of P2 purinergic receptors with cellular macromolecules.Naunyn-Schmiedeberg's archives of pharmacology · 2008
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Shintaro Yamamoto-MizumaCenter of Biomedical Research Excellence, Department of Pharmacology, University of Nevada School of Medicine, Reno 89557-0046, USA.
Ge-Xin Wang
Joseph R Hume
University of Nevada, Reno · US

Funding

Signal transduction pathways regulated by cell volumeP20RR015581 · NCRR · UNIVERSITY OF NEVADA RENO · PI VALENCIK, MARIA LYNN · 2000 to 2009
$19.5M
IONIC AND PHARMACOLOGICAL REGULATION OF VASCULAR CELLSR37HL049254 · NHLBI · UNIVERSITY OF NEVADA RENO · PI HUME, JOSEPH R · 1998 to 2007
$2.7M
IONIC AND PHARMACOLOGICAL REGULATION OF VASCULAR CELLSR01HL049254 · NHLBI · UNIVERSITY OF NEVADA RENO · PI HUME, JOSEPH R · 1993 to 1998
–
NCRR NIH HHS P20 RR015581NCRR NIH HHS P20RR15581NHLBI NIH HHS HL49254NHLBI NIH HHS R01 HL049254NHLBI NIH HHS R37 HL049254
6 · The paper itself

Abstract

The intracellular signalling pathways and molecular mechanisms responsible for P2-purinoceptor-mediated chloride (Cl(-)) currents (I(Cl,ATP)) were studied in mouse ventricular myocytes. In standard NaCl-containing extracellular solutions, extracellular ATP (100 microm) activated two different currents, I(Cl,ATP) with a linear I-V relationship in symmetrical Cl(-) solutions, and an inwardly rectifying cation conductance (cationic I(ATP)). Cationic I(ATP) was selectively inhibited by Gd(3+) and Zn(2+), or by replacement of extracellular NaCl by NMDG; I(Cl,ATP) was Cl(-) selective, and inhibited by replacement of extracellular Cl(-) by Asp(-); both currents were prevented by suramin or DIDS pretreatment. In GTPgammaS-loaded cells, I(Cl,ATP) was irreversibly activated by ATP, but cationic I(ATP) was still regulated reversibly. GDPbetaS prevented activation of the I(Cl,ATP,) even though pertussis toxin pretreatment did not modulate I(Cl,ATP). These results suggest that activation of I(Cl,ATP) occurs via a G-protein coupled P2Y purinergic receptor. The I(Cl,ATP) persistently activated by GTPgammaS, was inhibited by glibenclamide but not by DIDS, thus exhibiting known pharmacological properties of cystic fibrosis transmembrane conductance regulator (CFTR) Cl(-) channels. In ventricular cells of cftr(-/-) mice, extracellular ATP activated cationic I(ATP), but failed to activate any detectable I(Cl,ATP). These results provide compelling evidence that activation of CFTR Cl(-) channels in mouse heart are coupled to G-protein coupled P2Y purinergic receptors.

Indexed as

4,4'-Diisothiocyanostilbene-2,2'-Disulfonic AcidAdenosine TriphosphateAnimalsAspartic AcidCells, CulturedChloridesCystic Fibrosis Transmembrane Conductance RegulatorFemaleGadoliniumGlucosamineGlyburideGuanosine 5'-O-(3-Thiotriphosphate)Guanosine DiphosphateMaleMiceMice, Inbred C57BL4,4'-Diisothiocyanostilbene-2,2'-Disulfonic AcidAdenosine TriphosphateAspartic AcidChloridesCystic Fibrosis Transmembrane Conductance RegulatorGadoliniumGlucosamineGlyburideguanosine 5'-O-(2-thiodiphosphate)Guanosine 5'-O-(3-Thiotriphosphate)Guanosine DiphosphateN-methylglucosaminePertussis ToxinPurinergic P2 Receptor AntagonistsReceptors, Purinergic P2SodiumSuraminThionucleotidesZinc

Identifiers

PMID14978203
PMCPMC1664988
OpenAlexW2130789531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.